CPH has been shown to possess anti-tumor properties in various cancer types, including hepatocellular carcinoma, myeloma, leukemia, mantle cell lymphoma, breast cancer, and urothelial carcinoma by inducing apoptosis and cell cycle arrest [6–8]. This evidence concerns the gene CPE and mantle cell lymphoma.